KINEPOLIS GROUP 50.300 € (0,00 %) UMICORE 18.110 € (-2,84 %) AB INBEV 76.500 € (+1,19 %) VASTNED 27.650 € (+1,10 %) ONWARD MEDICAL 1.720 € (-2,82 %) ARGENX SE 886.600 € (+1,28 %) GIMV 50.500 € (-0,20 %) ENERGYVISION 17.980 € (+1,12 %) MELEXIS 57.650 € (+1,68 %) SOLVAY 24.700 € (+1,15 %) NYXOAH 0.790 € (-1,00 %) BEKAERT 42.750 € (+3,51 %) BPOST 0.863 € (-0,80 %) AEDIFICA 65.900 € (+0,53 %) WDP 19.760 € (+0,66 %) TITAN S.A. 45.740 € (-1,25 %) KBC 115.600 € (-4,34 %) CMB.TECH 15.640 € (+0,77 %) UCB 295.200 € (+1,34 %) COLRUYT 37.080 € (+0,05 %) EVS 17.720 € (-6,04 %) RECTICEL 12.900 € (+1,57 %) ASCENCIO 53.700 € (+0,19 %) ELIA GROUP 135.100 € (+0,67 %) AGEAS 79.250 € (+0,38 %) SOFINA 269.800 € (-0,30 %) LOTUS BAKERIES 14 200.000 € (+0,42 %) SYENSQO 79.500 € (-0,62 %) SIPEF 108.400 € (-0,73 %) CIE BOIS SAUVAGE 287.000 € (-0,35 %) OXURION 0.001 € (0,00 %) CELYAD ONCOLOGY 0.170 € (-5,03 %) KBC ANCORA 95.500 € (-1,95 %) DEME GROUP 168.600 € (+0,84 %) TINC 10.580 € (-0,19 %) FAGRON 24.200 € (-0,62 %) JENSEN-GROUP 76.000 € (-0,26 %) MONTEA 70.700 € (+1,29 %) SHURGARD 25.900 € (-0,96 %) SOLVAC 86.000 € (-1,15 %) ACKERMANS V.HAAREN 279.000 € (+1,09 %) TUBIZE-FIN 242.000 € (+0,75 %) BREDERODE 100.200 € (-0,60 %) CARE PROPERTY INV. 12.800 € (-0,31 %) AGFA-GEVAERT 0.361 € (+1,55 %) BARCO 6.265 € (+0,08 %) PROXIMUS 6.450 € (+1,65 %) XIOR 25.650 € (+0,20 %) OPTION 4.500 € (-3,85 %) RETAIL ESTATES 63.500 € (-0,94 %) HOME INVEST BE. 18.040 € (+0,78 %) ECONOCOM GROUP 1.490 € (-2,61 %) BIOTALYS 1.904 € (-3,74 %) HYLORIS 3.980 € (-5,24 %) D'IETEREN GROUP 176.000 € (0,00 %) AZELIS GROUP 12.000 € (+2,30 %) VGP 65.600 € (+1,39 %) EKOPAK 2.900 € (+3,57 %) NEXTENSA 45.815 € (-0,73 %) WERELDHAVE BELGIUM 52.000 € (0,00 %)
LVMH 404.700 € (+0,40 %)
TOTALENERGIES 80.630 € (+1,59 %)
HEIJMANS KON 87.150 € (-1,13 %)
VALEO 11.255 € (-2,34 %)
COMPAGNIE ODET 1 020.000 € (+2,00 %)
SCHNEIDER ELECTRIC 244.800 € (+0,95 %)
SHELL PLC 44.120 € (+0,78 %)
COVIVIO HOTELS 19.850 € (-2,22 %)
ADYEN 868.000 € (-0,75 %)
ASM INTERNATIONAL 724.200 € (-0,47 %)
ABEO 6.700 € (+3,72 %)
SAFRAN 312.300 € (-0,06 %)
ASML HOLDING 1 376.800 € (-1,92 %)
THALES 227.400 € (-1,30 %)
BE SEMICONDUCTOR 158.050 € (-1,06 %)
HERMES INTL 1 352.500 € (-0,07 %)
AIRBUS 208.250 € (-1,16 %)
OCI 4.090 € (0,00 %)
KENDRION 17.940 € (0,00 %)
ING GROEP N.V. 30.010 € (-0,50 %)
ENGIE 25.140 € (+1,53 %)
EURONEXT 166.200 € (-0,72 %)
AHOLD DEL 35.300 € (+0,23 %)
SANOFI 87.980 € (+1,58 %)
ABIVAX 82.500 € (-0,96 %)
EUROPLASMA 0.000 € (0,00 %)
ADP 116.800 € (-0,17 %)
UNILEVER 59.180 € (+0,94 %)
CREDIT AGRICOLE 15.830 € (-0,25 %)
HAFFNER ENERGY 0.568 € (-1,22 %)
VEOLIA ENVIRON. 34.660 € (+1,05 %)
UNIBAIL-RODAMCO-WE 93.140 € (-0,26 %)
OSE IMMUNO 1.702 € (-1,96 %)
GENOWAY 2.030 € (+6,28 %)
ARCADIS 47.460 € (+0,38 %)
GTT 186.800 € (-0,11 %)
STMICROELECTRONICS 42.340 € (+0,39 %)
SPINEGUARD 0.090 € (+1,35 %)
BRUNEL INTERNAT 7.000 € (+2,04 %)
MEDINCELL 29.080 € (-2,48 %)
LAURENT-PERRIER 79.400 € (-1,49 %)
CSG 10.016 € (-4,97 %)
SMCP 4.112 € (-1,15 %)
OMER-DECUGIS & CIE 7.000 € (+0,86 %)
S.E.B. 57.150 € (-0,70 %)
PHILIPS KON 27.260 € (+0,48 %)
BIOPHYTIS 0.039 € (-4,38 %)
EXOR NV 73.400 € (-1,41 %)
SOLUTIONS 30 SE 0.550 € (+3,19 %)
EIFFAGE 109.350 € (+0,60 %)
SWORD GROUP 34.900 € (+3,10 %)
ORANGE 15.485 € (+0,42 %)
COHERIS 7.020 € (0,00 %)
CTP 12.860 € (-0,46 %)
AIR LIQUIDE 192.840 € (+0,35 %)
MR BRICOLAGE 2.750 € (-1,08 %)
UV GERMI 2.350 € (+1,29 %)
SIGNIFY NV 15.670 € (-1,20 %)
INTERPARFUMS 36.380 € (-0,27 %)
MEDIAN TECH BSA 3.280 € (+9,33 %) News Réglementées
|
31/08/2026 09:00
Original-Research: Verbio SE (von NuWays AG): BUYOriginal-Research: Verbio SE - from NuWays AG Classification of NuWays AG to Verbio SE
Renewable fuels entering a new cycle; INITIATE WITH BUY VERBIO is one of Europe's leading integrated biorefineries, converting agricultural feedstocks and residues into biodiesel, bioethanol, biomethane, renewable chemicals and higher-value co-products. Its production network across Germany, the US, Canada and India maximises the value extracted from every tonne of biomass, while providing diversification across products, geographies, feedstocks and regulatory regimes. Following two years of depressed profitability, mainly due to distortions in the German GHG quota market, weak bioethanol economics and the US ramp-up, VERBIO has entered a structural earnings recovery. Preliminary FY25/26 EBITDA reached € 192m (+€ 178m yoy). Excluding a c.€ 20m one-off benefit from GHG quota inventory write-down reversals, underlying EBITDA recovered to c.€ 172m, driven mainly by the normalisation of German GHG quota economics (eNuW: c.2/3 of EBITDA growth), stronger European bioethanol spreads and higher US production. Importantly, the regulatory backdrop is improving as VERBIO completes its largest investment programme. Higher GHG quota prices increase the value of the existing European asset base, while rising utilisation in Nevada, the gradual conversion of South Bend towards integrated ethanol/RNG production and renewable chemicals provide additional operating leverage. The integrated bioethanol/biomethane business remains structurally the most attractive part of the portfolio, combining multiple revenue streams, favourable long-term demand fundamentals and additional upside from the monetisation of CO₂ savings. We believe VERBIO is transitioning from an investment-led to a monetisation-led phase. In addition to the ramp-up of recently completed assets, c.0.66m tonnes of accumulated 2024 GHG quotas (eNuW) represent significant latent value. At our € 400/tCO₂ assumption, these imply c.€ 227m net cash proceeds, which we expect to be monetised across FY27/28e and FY28/29e. The next two months could prove particularly important. FY25/26 results in late September should provide further detail on the earnings recovery, while the Capital Markets Day in early October should offer greater visibility on medium-term earnings potential, capital allocation and the rollout of renewable chemicals. We initiate coverage with BUY and a PT of € 41, based primarily on average normalised FCF across FY27/28e and FY28/29e. Assuming € 400/tCO₂ GHG quota prices, below current spot levels, and no exceptionally strong biofuel margin environment, our forecasts imply an adjusted FCF yield of c.10% in FY27/28e, rising further in FY28/29e, while the market still assigns limited value to regulatory normalisation, recently commissioned assets and renewable chemicals. You can download the research here: verbio-se-2026-08-31-fullnoteinitiation-en-cab0f For additional information visit our website: https://www.nuways-ag.com/research Contact for questions: NuWays AG - Equity Research Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 Hamburg, Germany ++++++++++ Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse. ++++++++++ The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. 2390714 31.08.2026 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||
© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière